Member Info for Bladderman

Both companies are great imo but i think this needs to be clarified.
GDR test production of 10k per hour in a day is 240k ....in a month is 8M PCR tests

NCYT are producing 4M PCR tests but will increase production up to 8M over the next 2-3 months.

Slightly behind the curve but GDR will be available for global shipping in only 4 weeks. NCYT has FDA approval but ours can be shipped at room temp and valued at around a tenth (£29M v £250M) also we have twice the current production rate. We def have a lot of catching up to do!

In other words one month of sales (£40M) is equivalent to 110p Market cap every month lol

Yeh sorry bit hungover today lol.
So 10k units per hour means we will be manufacturing 8M tests in a 96 well PCR plate format a month. NCYT hope to increase to 8M tests equivalent over the next 2-3 months and we're valued at around a tenth of NCYT so plenty of upside dont you think ....!! But ours is not temperature sensitive. Just do the maths. IF £5 a test that's £40M a month potentially - oh wow

No it'll depend on how many PCR machines a diagnostics lab has

Note 'significant scale' and 'global basis'. The global market will be phenomenal....£29M lol

David Budd, Chief Executive Officer of Genedrive plc, says: "We have extensive experience working with the Cytiva team on assay development and manufacturing for our Point of Care HCV, AIHL, and military programmes. We are pleased to now apply that partnership in a high throughput manufacturing process, which we believe places us amongst a small group of companies that have the capability to produce simple assay solutions at significant scale.

Gabriel Fernandez de Pierola, General Manager, Genomics and Diagnostics at Cytiva, says: "The spread of the SARS-COV-2 virus is driving an urgent need for extensive testing, particularly amongst patients and health workers. Critical to overcoming the pandemic is being able to produce high volumes of reliable tests which can be shipped easily on a global basis with minimal environmental impact.

Yes and some I reckon. Even then that's only a market cap of £37M which is nothing with the product that's about to hit the global market

Think it's an amazing turn around to have this product market ready in 4 weeks with 100% commercial rights and sat at £29M lol

Not sure why that would be as 10k tests per hour is very efficient for mass screening. Even if it were the potential global market ( 60M people inthe UK) is astronomical compared to 8 billion world wide

Also it is easy to obtain 96 well plates as these are readily available from science product providers. It will be a lot cheaper to do mass testing this way as opposed to £25 per sample suggested so serve different needs. Great to get these new testing approaches to market. I'm not sure how readily ODX devices will take to manufacture to meet demand as is quite specialist. Cytiva have Lyostable ready to go for GDR's product

Professor Balachandran said in a statement. “But this is not a normal situation. According to the Imperial College model, this might last for 18 months. And cases will rise over the next few months. Everyone is crying out for these tests, and many will take a long time. We haven’t got a long time, so anything like this is going to help. Speed is essential.

Check out the model - 18 months of testing and cases will continue to rise.

Demand for testing globally is going to be phenonmonal. GDR devices can process up to 10k an hour so is very high through put and will meet different needs to ODX's which can do six at a time. Both will do very well.
Five weeks last Monday so product ready to market within the next 4 weeks!!

I think you undererestimate the global magnitude of this pandemic - unfortunately it's going nowhere for a long time.

AVCT is now £165M and touched £175M and rightfully so. A different company but 6x our value at present. NCYT is £240M (9-10x) - there is a huge disconnect here so we need to be revalued. I need more of these on Monday before they're over £1 lol

We could readily be at 150-160p (£60M) before the product is ready. Then wait for the 50% uplift on that news (£90-£100M on that news surely) - then orders could very well take us to £200M+

Just don't get mugged on the way up.

A £100-£150M company is certainly achievable if every thing falls into place over this timeframe. Next week here is going to be massive as still sub £30M which is bonkers because of their potential significance in Covid testing.

10k tests per hour is about as high throughput as we'll see through this pandemic! Also it's PCR brand compatibility cannot be over stated.

Crumbs...Also a £12k and £9.2k and £8.5k were also buys in the last 15 minutes

Also the £20k and £17k delayed trades in red were actually buys in the last half hour. Not chip money that's for sure!!!

Observation - great to set us up for the Monday run.

They haven't crossed 2.61% twice two days apart lol

Why would they RNS to say they have the same amount. That TR1 is wrong lol